Skip to Content Skip to Search
About us new hero

About us

We are a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer.

Arthur, Oncology Scientist, US

We have three global businesses that research, develop and manufacture innovative pharmaceutical medicines, vaccines and consumer healthcare products. Every day, we help improve the health of millions of people around the world.

Our goal is to be one of the world’s most innovative, best performing and trusted healthcare companies.

Our values and expectations are at the heart of everything we do - so that together we can deliver extraordinary impact for our patients and consumers and make GSK a brilliant place to work.

Our values are Patient focus, Transparency, Respect, Integrity.
Our expectations are Courage, Accountability, Development, Teamwork.

What we do

We aim to bring differentiated, high-quality and needed healthcare products to as many people as possible, with our 3 global businesses, scientific and technical know-how and talented people.

Pharmaceuticals

T-cells attacking a cancer cell
Immune system T-cells attacking a cancer cell

Vaccines

Herpes zoster virus of shingles
Herpes zoster virus of shingles

Consumer Healthcare

Novamin, a key technology in Sensodyne
Novamin, a key technology in Sensodyne Repair and Protect

How we do it

Everyone at GSK is focused on our 3 long-term priorities – Innovation, Performance, Trust, all powered by our performance-focused culture.

Innovation

We invest in scientific and technical excellence to develop and launch a pipeline of new products that meet the needs of patients, payers and consumers.

  • £4.3bn

    adjusted R&D investment in 2019

  • 35

    new medicines in development at Q2 2020

  • 15

    new vaccines in development at Q2 2020

Performance

We deliver growth by investing effectively in our business, developing our people and executing competitively.
 

  • £33.8bn

    turnover in 2019

  • £9bn

    adjusted operating profit in 2019

  • £5.1bn

    free cash flow in 2019

  • £4bn

    dividends paid in 2019

Trust

We are a responsible company - using our science and technology to address health needs, we are focused on making our products affordable and available, and being a modern employer.

  • 78%

    employee engagement score on our latest employee survey

  • £263m

    donated in 2019 to community health programmes

  • 1st

    in Access to Medicines Index since the assessment began in 2008